Medincell Sa Stock Price Prediction
| MDCLF Stock | USD 14.00 7.02 100.57% |
Oversold Vs Overbought
0
Oversold | Overbought |
Using MedinCell hype-based prediction, you can estimate the value of MedinCell SA from the perspective of MedinCell response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in MedinCell to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying MedinCell because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
MedinCell after-hype prediction price | USD 14.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
MedinCell |
MedinCell After-Hype Price Prediction Density Analysis
As far as predicting the price of MedinCell at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in MedinCell or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of MedinCell, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
MedinCell Estimiated After-Hype Price Volatility
In the context of predicting MedinCell's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on MedinCell's historical news coverage. MedinCell's after-hype downside and upside margins for the prediction period are 0.70 and 28.25, respectively. We have considered MedinCell's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
MedinCell is relatively risky at this time. Analysis and calculation of next after-hype price of MedinCell SA is based on 3 months time horizon.
MedinCell Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as MedinCell is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MedinCell backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with MedinCell, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.80 | 14.25 | 0.00 | 0.58 | 0 Events / Month | 3 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
14.00 | 14.00 | 0.00 |
|
MedinCell Hype Timeline
MedinCell SA is now traded for 14.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.58. MedinCell is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is now at 0.8%. %. The volatility of related hype on MedinCell is about 1962.81%, with the expected price after the next announcement by competition of 13.42. About 48.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.88. MedinCell SA had not issued any dividends in recent years. The entity had 50:1 split on the 16th of March 2017. Assuming the 90 days horizon the next expected press release will be uncertain. Check out MedinCell Basic Forecasting Models to cross-verify your projections.MedinCell Related Hype Analysis
Having access to credible news sources related to MedinCell's direct competition is more important than ever and may enhance your ability to predict MedinCell's future price movements. Getting to know how MedinCell's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how MedinCell may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ADPT | Adaptive Biotechnologies Corp | (0.18) | 9 per month | 4.03 | 0.1 | 9.93 | (8.39) | 31.46 | |
| RPHM | Reneo Pharmaceuticals | 0.30 | 8 per month | 2.63 | 0.09 | 6.12 | (4.88) | 15.91 | |
| LEGN | Legend Biotech Corp | (1.70) | 10 per month | 0.00 | (0.16) | 4.53 | (6.01) | 17.18 | |
| VIR | Vir Biotechnology | (0.27) | 6 per month | 4.18 | (0) | 5.50 | (7.22) | 35.87 | |
| APLS | Apellis Pharmaceuticals | (1.78) | 10 per month | 2.49 | 0.01 | 4.57 | (4.00) | 15.91 |
MedinCell Additional Predictive Modules
Most predictive techniques to examine MedinCell price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for MedinCell using various technical indicators. When you analyze MedinCell charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About MedinCell Predictive Indicators
The successful prediction of MedinCell stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as MedinCell SA, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of MedinCell based on analysis of MedinCell hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to MedinCell's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to MedinCell's related companies.
Story Coverage note for MedinCell
The number of cover stories for MedinCell depends on current market conditions and MedinCell's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that MedinCell is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about MedinCell's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
MedinCell Short Properties
MedinCell's future price predictability will typically decrease when MedinCell's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of MedinCell SA often depends not only on the future outlook of the potential MedinCell's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MedinCell's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 25.1 M |
Complementary Tools for MedinCell Pink Sheet analysis
When running MedinCell's price analysis, check to measure MedinCell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedinCell is operating at the current time. Most of MedinCell's value examination focuses on studying past and present price action to predict the probability of MedinCell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedinCell's price. Additionally, you may evaluate how the addition of MedinCell to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |